Implications of Proposed Medicare Reforms to Counteract High Cancer Drug Prices

MeSH terms

• Antineoplastic Agents / economics*
• Cost Control*
• Cost Sharing
• Drug Costs*
• Medicare Part B / economics*
• Practice Patterns, Physicians' / statistics & numerical data
• Prescription Drugs / economics
• Quality of Health Care
• Reimbursement, Incentive
• Risk Sharing, Financial
• United States